Vitorovic-Todorovic MD, Worek F, Perdih A, Bauk SD, Vujatovic TB, Cvijetic IN (2019) <br />The in vitro protective effects of the three novel nanomolar reversible inhibitors of human cholinesterases against irreversible inhibition by organophosphorous chemical warfare agents<br /><i>Chemico-Biological Interactions</i> <b>309</b>: 108714<br /><br />Vitorovic-Todorovic MD, Koukoulitsa C, Juranic IO, Mandic LM, Drakulic BJ (2014) <br />Structural modifications of 4-aryl-4-oxo-2-aminylbutanamides and their acetyl- and butyrylcholinesterase inhibitory activity. Investigation of AChE-ligand interactions by docking calculations and molecular dynamics simulations<br /><i>Eur Journal of Medicinal Chemistry</i> <b>81C</b>: 158<br /><br />Vitorovic-Todorovic MD, Cvijetic IN, Juranic IO, Drakulic BJ (2012) <br />The 3D-QSAR study of 110 diverse, dual binding, acetylcholinesterase inhibitors based on alignment independent descriptors (GRIND-2). The effects of conformation on predictive power and interpretability of the models<br /><i>J Mol Graph Model</i> <b>38C</b>: 194<br /><br />Vitorovic-Todorovic MD, Juranic IO, Mandic LM, Drakulic BJ (2010) <br />4-Aryl-4-oxo-N-phenyl-2-aminylbutyramides as acetyl- and butyrylcholinesterase inhibitors. Preparation, anticholinesterase activity, docking study, and 3D structure-activity relationship based on molecular interaction fields<br /><i>Bioorganic & Medicinal Chemistry</i> <b>18</b>: 1181<br /><br />Novakovic SB, Vitorovic-Todorovic MD, Bogdanovic GA, Drakulic BJ (2008) <br />Weak intermolecular interactions in 11-chloro-2,3,4,5-tetrahydro-1H-cyclohepta[b]quinoline<br /><i>Acta Crystallographica C</i> <b>64</b>: o502<br /><br />